US Edition
Instylla Appoints Sean Boyle as Chief Executive Officer - Endovascular Today
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Instylla Appoints Sean Boyle as Chief Executive Officer - Endovascular Today
August 5, 2025—Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced the appointment of Sean Boyle as Chief Executive Officer. Boyle will replace Amar Sawhney as CEO. Sawhney will continue as Chairman of the Board of the company. According to the company, Boyle brings 15 years of leadership in the medical device industry with experience in diverse business units. Before joini…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
